Standard Biotools Stock Forward View - Triple Exponential Smoothing
| LAB Stock | USD 1.43 0.05 3.38% |
Standard Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Standard Biotools stock prices and determine the direction of Standard Biotools's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Standard Biotools' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The relative strength index (RSI) of Standard Biotools' share price is at 50. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Standard Biotools, making its price go up or down. Momentum 50
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.02) | EPS Estimate Current Year (0.11) | EPS Estimate Next Year (0.04) | Wall Street Target Price 1.55 | Quarterly Revenue Growth (0.14) |
Using Standard Biotools hype-based prediction, you can estimate the value of Standard Biotools from the perspective of Standard Biotools response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Standard Biotools using Standard Biotools' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Standard using crowd psychology based on the activity and movement of Standard Biotools' stock price.
Standard Biotools Short Interest
A significant increase or decrease in Standard Biotools' short interest from the previous month could be a good indicator of investor sentiment towards Standard. Short interest can provide insight into the potential direction of Standard Biotools stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.2829 | Short Percent 0.0414 | Short Ratio 5.66 | Shares Short Prior Month 10.3 M | 50 Day MA 1.4474 |
Standard Relative Strength Index
The Triple Exponential Smoothing forecasted value of Standard Biotools on the next trading day is expected to be 1.43 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.79.Standard Biotools Hype to Price Pattern
Investor biases related to Standard Biotools' public news can be used to forecast risks associated with an investment in Standard. The trend in average sentiment can be used to explain how an investor holding Standard can time the market purely based on public headlines and social activities around Standard Biotools. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Standard Biotools' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Standard Biotools.
Standard Biotools Implied Volatility | 3.08 |
Standard Biotools' implied volatility exposes the market's sentiment of Standard Biotools stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Standard Biotools' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Standard Biotools stock will not fluctuate a lot when Standard Biotools' options are near their expiration.
The Triple Exponential Smoothing forecasted value of Standard Biotools on the next trading day is expected to be 1.43 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.79. Standard Biotools after-hype prediction price | USD 1.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Standard Biotools to cross-verify your projections. Prediction based on Rule 16 of the current Standard contract
Based on the Rule 16, the options market is currently suggesting that Standard Biotools will have an average daily up or down price movement of about 0.19% per day over the life of the 2026-03-20 option contract. With Standard Biotools trading at USD 1.43, that is roughly USD 0.002753 . If you think that the market is fully incorporating Standard Biotools' daily price movement you should consider acquiring Standard Biotools options at the current volatility level of 3.08%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Standard Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Standard Biotools' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Standard Biotools' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Standard Biotools stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Standard Biotools' open interest, investors have to compare it to Standard Biotools' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Standard Biotools is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Standard. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Standard Biotools Additional Predictive Modules
Most predictive techniques to examine Standard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Standard using various technical indicators. When you analyze Standard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Standard Biotools Triple Exponential Smoothing Price Forecast For the 31st of January
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Standard Biotools on the next trading day is expected to be 1.43 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 2.79.Please note that although there have been many attempts to predict Standard Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Standard Biotools' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Standard Biotools Stock Forecast Pattern
| Backtest Standard Biotools | Standard Biotools Price Prediction | Buy or Sell Advice |
Standard Biotools Forecasted Value
In the context of forecasting Standard Biotools' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Standard Biotools' downside and upside margins for the forecasting period are 0.01 and 5.91, respectively. We have considered Standard Biotools' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Standard Biotools stock data series using in forecasting. Note that when a statistical model is used to represent Standard Biotools stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.0118 |
| MAD | Mean absolute deviation | 0.0473 |
| MAPE | Mean absolute percentage error | 0.0331 |
| SAE | Sum of the absolute errors | 2.7915 |
Predictive Modules for Standard Biotools
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Standard Biotools. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Standard Biotools After-Hype Price Density Analysis
As far as predicting the price of Standard Biotools at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Standard Biotools or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Standard Biotools, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Standard Biotools Estimiated After-Hype Price Volatility
In the context of predicting Standard Biotools' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Standard Biotools' historical news coverage. Standard Biotools' after-hype downside and upside margins for the prediction period are 0.07 and 5.88, respectively. We have considered Standard Biotools' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Standard Biotools is dangerous at this time. Analysis and calculation of next after-hype price of Standard Biotools is based on 3 months time horizon.
Standard Biotools Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Standard Biotools is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Standard Biotools backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Standard Biotools, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.33 | 4.48 | 0.03 | 0.22 | 6 Events / Month | 6 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.43 | 1.40 | 2.10 |
|
Standard Biotools Hype Timeline
On the 30th of January Standard Biotools is traded for 1.43. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of -0.22. Standard is forecasted to decline in value after the next headline, with the price expected to drop to 1.4. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -2.1%, whereas the daily expected return is now at 0.33%. The volatility of related hype on Standard Biotools is about 672.67%, with the expected price after the next announcement by competition of 1.21. About 77.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Standard Biotools has Price/Earnings To Growth (PEG) ratio of 0.31. The entity recorded a loss per share of 0.39. The firm had not issued any dividends in recent years. Standard Biotools had a split on the 6th of December 2001. Considering the 90-day investment horizon the next forecasted press release will be in about 6 days. Check out Historical Fundamental Analysis of Standard Biotools to cross-verify your projections.Standard Biotools Related Hype Analysis
Having access to credible news sources related to Standard Biotools' direct competition is more important than ever and may enhance your ability to predict Standard Biotools' future price movements. Getting to know how Standard Biotools' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Standard Biotools may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VREX | Varex Imaging Corp | (6.89) | 22 per month | 3.12 | 0.08 | 4.43 | (3.53) | 18.19 | |
| CBLL | CeriBell | (0.59) | 11 per month | 2.32 | 0.20 | 6.82 | (4.90) | 18.00 | |
| CGEM | Cullinan Oncology LLC | 0.31 | 10 per month | 3.96 | 0.12 | 8.60 | (8.82) | 45.76 | |
| AVNS | Avanos Medical | 0.58 | 9 per month | 1.82 | 0.04 | 4.68 | (3.06) | 9.85 | |
| SY | So Young International | (0.03) | 26 per month | 5.36 | 0.01 | 7.04 | (8.60) | 31.96 | |
| ADCT | ADC Therapeutics SA | 0.03 | 10 per month | 0.00 | (0.02) | 8.49 | (7.06) | 22.84 | |
| TMCI | Treace Medical Concepts | (0.09) | 8 per month | 0.00 | (0.27) | 5.60 | (5.62) | 31.38 | |
| KIDS | Orthopediatrics Corp | (0.13) | 10 per month | 2.16 | (0) | 3.72 | (2.97) | 16.89 | |
| CTKB | Cytek Biosciences | 0.04 | 6 per month | 2.76 | 0.08 | 6.42 | (4.88) | 26.01 | |
| BVS | Bioventus | 0.11 | 7 per month | 2.18 | 0.05 | 5.12 | (3.49) | 22.05 |
Other Forecasting Options for Standard Biotools
For every potential investor in Standard, whether a beginner or expert, Standard Biotools' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Standard Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Standard. Basic forecasting techniques help filter out the noise by identifying Standard Biotools' price trends.Standard Biotools Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Standard Biotools stock to make a market-neutral strategy. Peer analysis of Standard Biotools could also be used in its relative valuation, which is a method of valuing Standard Biotools by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Standard Biotools Market Strength Events
Market strength indicators help investors to evaluate how Standard Biotools stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Standard Biotools shares will generate the highest return on investment. By undertsting and applying Standard Biotools stock market strength indicators, traders can identify Standard Biotools entry and exit signals to maximize returns.
Standard Biotools Risk Indicators
The analysis of Standard Biotools' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Standard Biotools' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting standard stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.28 | |||
| Semi Deviation | 3.62 | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.68 | |||
| Downside Variance | 15.83 | |||
| Semi Variance | 13.11 | |||
| Expected Short fall | (4.01) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Standard Biotools
The number of cover stories for Standard Biotools depends on current market conditions and Standard Biotools' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Standard Biotools is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Standard Biotools' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Standard Biotools Short Properties
Standard Biotools' future price predictability will typically decrease when Standard Biotools' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Standard Biotools often depends not only on the future outlook of the potential Standard Biotools' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Standard Biotools' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 352.7 M | |
| Cash And Short Term Investments | 292.9 M |
Check out Historical Fundamental Analysis of Standard Biotools to cross-verify your projections. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. Expected growth trajectory for Standard significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Standard Biotools assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.39) | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets | Return On Equity |
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Standard Biotools' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Standard Biotools represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Standard Biotools' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.